For all queries call: +1.732.777.1111 | info@sabinsa.com
ForsLean®
  • ForsLean®
    • Overview
    • Chemistry
    • Mechanism of Action
    • Sustainability
  • Research
    • Clinical Studies
      • INDIA
      • JAPAN
      • USA
    • Safety Aspects
  • IP Rights
  • Achievements
  • Newsroom
    • Press Releases
    • Newsletters
    • White Papers
    • Articles
    • Videos
    • AD’s
    • FAQ
  • About Sabinsa
  • Contact Us

Press Releases

Latest Press Releases
March 30, 2001 Big

ForsLean addresses overall metabolic health and not just weight management, says Mr. Shaheen Majeed, President-Worldwide, Sabinsa

May 2, 2019
At April’s SupplySide East trade show, Sabinsa Corp. (East Windsor, NJ) explained how its branded Coleus forskohlii extract ingredient, ForsLean, is approaching the weight management.
Read more
ForsLean

Sabinsa Awarded New Patents For ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims

April 4, 2019
Sabinsa announces that it has been awarded Japanese Patent Number 6472453, US Patent Number 10085963, and Australian Patent Number 2015351423, entitled “Process and compositions for.
Read more
coleus forskohlii

Sabinsa Publishes ForsLean® Safety Data in International Journal of Pharmacy & Pharmaceutical Research

January 19, 2016
Sabinsa Corporation and Sami Labs founder Dr. Muhammed Majeed was lead author of a paper published on the cumulative safety data of ForsLean®, the company’s.
Read more
Press Releases
Sabinsa Granted Forskolin Solubility Patent In China

Sabinsa Notifies Alchem as to Status of Its Forskohlin(ForsLean®) Patent

  • May 5, 2008
  • .Press Releases
  • .0 Comments
Sabinsa Corporation announced today that it has notified Alchem International as to the status of its patent covering the use of Forskohlin (ForsLean®), and ha...
Read More
Posted by forslean
  • Share
  • Tweet
Sabinsa Granted Forskolin Solubility Patent In China

Sabinsa Secures Patent For ForsLean® In Canada

  • February 25, 2008
  • .Press Releases
  • .0 Comments
Sabinsa Corporation today announced that it has secured a patent in Canada for its branded ingredient ForsLean® , a standardized extract of Coleus forskohlii r...
Read More
Posted by forslean
  • Share
  • Tweet
Newsroom-17

Sabinsa Sues to Protect Its Piperine (BioPerine®) and Forskohlin (ForsLean®) Patents

  • July 26, 2007
  • .Press Releases
  • .0 Comments
Sabinsa Corporation announced today that it has sued BioGreen NutraChem Inc. in the United States District Court in the Eastern District of New York for infring...
Read More
Posted by forslean
  • Share
  • Tweet
Sabinsa Granted Forskolin Solubility Patent In China

Sabinsa Successfully Protects Its Piperine (BioPerine®) and Forskohlin (ForsLean®) Patents

  • July 2, 2007
  • .Press Releases
  • .0 Comments
Sabinsa Corporation announced today that it has successfully concluded its patent infringement lawsuit against DNP International, Inc. in the United States Dist...
Read More
Posted by forslean
  • Share
  • Tweet
Article-3

Sabinsa Corporation is Awarded Thomas Alva Edison Patent Award

  • November 23, 2004
  • .Press Releases
  • .0 Comments
Piscataway, NJ – Sabinsa Corporation, a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals, was awarded t...
Read More
Posted by forslean
  • Share
  • Tweet
Article-5

ForsLean® Imporves Body Composition According to Study Published In The Journal of Obesity Research

  • October 3, 2004
  • .Press Releases
  • .0 Comments
Piscataway, NJ October 03, 2004- A recent study published in the August 2005 Journal of Obesity Research entitled “Body Composition and Hormonal Adaptations A...
Read More
Posted by forslean
  • Share
  • Tweet
Newsroom-03

Sabinsa Successfully Defends Patent Infringement Lawsuit Against GCI Nutrients

  • April 22, 2003
  • .Press Releases
  • .0 Comments
Sabinsa Corporation has once again successfully protected its intellectual property (IP). Mark C. Sysler, Sabinsa’s Sr. EVP for Marketing and Sales today anno...
Read More
Posted by forslean
  • Share
  • Tweet
Newsroom-14

Sabinsa Wins ForsLean® Patent Infringement Suit Against Indfrag Ltd.

  • October 11, 2002
  • .Press Releases
  • .0 Comments
Sabinsa Corporation Senior Executive Vice President, Mark C. Sysler announced today that a Final Judgment has been entered in the patent infringement lawsuit th...
Read More
Posted by forslean
  • Share
  • Tweet
ForsLean

Sabinsa ForsLean® Now Water Soluble

  • May 29, 2002
  • .Press Releases
  • .0 Comments
Sabinsa Corporation Senior Executive Vice President, Mark C. Sysler announced today that a Final Judgment has been entered in the patent infringement lawsuit th...
Read More
Posted by forslean
  • Share
  • Tweet
July 17, 2001 Big

Science Behind ForsLean® Garners Best New Dietary Supplement Product Of The Year Award For Sabinsa

  • July 17, 2001
  • .Press Releases
  • .0 Comments
Sami Labs, Ltd., the research and manufacturing arm of Sabinsa Corporation, was recently notified that it will be the recipient of two Export awards for the yea...
Read More
Posted by forslean
  • Share
  • Tweet
1 2 3

Recent Press Releases

  • ForsLean addresses overall metabolic health and not just weight management, says Mr. Shaheen Majeed, President-Worldwide, Sabinsa

    02 May. 2019
    View Post
  • Sabinsa Awarded New Patents For ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims

    04 April. 2019
    View Post
  • Sabinsa Publishes ForsLean® Safety Data in International Journal of Pharmacy & Pharmaceutical Research

    19 January. 2016
    View Post
  • Sabinsa Introduces Softgel Ready ForsLean® Soft Extracts Amid Exponential Growth In Coleus Demand: Company Cautions Against Low Quality Spam Knockoffs

    08 July. 2014
    View Post
  • Sabinsa Receives Payment from Creative Compounds for ForsLean® Trademark Infringement

    10 July. 2012
    View Post
  • Creative Compounds’ Attempt to Continue Trademark Infringement of Sabinsa’s ForsLean® Rejected by US Supreme Court

    09 February. 2011
    View Post
  • Sabinsa Granted Forskolin Solubility Patent In China

    15 December. 2010
    View Post
  • Sabinsa’s ForsLean® Gets PI Numbers From TGA To Enter Australian Market

    12 July. 2010
    View Post
  • US Appeals Court Finds Creative Compounds Guilty of Trademark Infringement Against Sabinsa’s ForsLean®

    14 June. 2010
    View Post
  • Sabinsa Secures International Forskolin Patent: Granted In Republic of South Africa & Singapore

    12 September. 2008
    View Post
About Sabinsa

Sabinsa is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.

Read More...
Headquarters

Sabinsa Corporation

20 Lake Drive 

East Windsor

NJ 08520, USA

Tel : +1 732 777 1111

Fax: +1 732 777 1443

info@sabinsa.com
Global Contact List
USAIndia
Utah, USAJapan
AustraliaPoland
BrasilKorea
CanadaSouth Africa
ChinaVietnam
Germany 
Contact Us

©2021 Sabinsa. All Rights Reserved | Powered by Edkal Technologies | Privacy Policy | Sitemap | Terms of Use | Disclaimer

Disclaimer

US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.